🇺🇸 FDA

Intelligence Platform

Patents

Browse 12 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11826322

Pre-filled syringe

Teva Pharmaceuticals USA, Inc. · Granted Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10835503

Pre-filled syringe

Teva Pharmaceuticals USA, Inc. · Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10640487

Solid state forms of Nilotinib salts

Teva Pharmaceuticals USA, Inc. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10035802

Solid state forms of ibrutinib

Teva Pharmaceuticals USA, Inc. · Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609856

Crystalline forms of Febuxostat

Teva Pharmaceuticals USA, Inc. · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415481

Crystalline form of febuxostat

Teva Pharmaceuticals USA, Inc. · Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8222282

Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine

Teva Pharmaceuticals USA, Inc. · Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531656

Synthesis of gatifloxacin

Teva Pharmaceuticals USA, Inc. · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7456207

Vaginal pharmaceutical compositions and methods for preparing them

Teva Pharmaceuticals USA, Inc. · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7396839

Crystalline forms of gatifloxacin

Teva Pharmaceuticals USA, Inc. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6306436

Stabilized, acid-free formulation for sustained release of bupropion hydrochloride

Teva Pharmaceuticals USA, Inc. · Granted Tue Oct 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6017531

Hydrophilic composition containing protease produced by Vibrio

Conn. / Teva Pharmaceuticals USA, Inc. · Granted Tue Jan 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired